Search

Your search keyword '"Talos DM"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Talos DM" Remove constraint Author: "Talos DM"
30 results on '"Talos DM"'

Search Results

2. Hyperactive neuronal networks facilitate tau spread in an Alzheimer's disease mouse model.

3. Hyperexcitability precedes CA3 hippocampal neurodegeneration in a dox-regulatable TDP-43 mouse model of ALS-FTD.

4. Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer's disease and 5XFAD mice.

5. Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5 R59X knock-in mice.

6. Reversible synaptic adaptations in a subpopulation of murine hippocampal neurons following early-life seizures.

7. Discovery of E2730, a novel selective uncompetitive GAT1 inhibitor, as a candidate for anti-seizure medication.

8. Anti-seizure efficacy of perampanel in two established rodent models of early-life epilepsy.

9. Optical Redox Imaging of Ex Vivo Hippocampal Tissue Reveals Age-Dependent Alterations in the 5XFAD Mouse Model of Alzheimer's Disease.

10. The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.

11. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.

12. Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy.

13. Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.

14. Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.

15. Subunit composition of glutamate and gamma-aminobutyric acid receptors in status epilepticus.

16. Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex.

17. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model.

18. Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures.

19. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

20. The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway.

21. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.

22. Developmental regulation of group I metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia.

23. Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia.

24. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.

25. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.

26. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival.

27. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex.

28. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex.

29. NKCC1 transporter facilitates seizures in the developing brain.

30. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

Catalog

Books, media, physical & digital resources